Jove
Visualize
Contact Us

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

618
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
618
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

2.7K
Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
2.7K
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

735
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
735
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

455
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
455
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

3.6K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.6K
Dialysis01:15

Dialysis

1.7K
Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New options to manage epidermolysis bullosa.

Wounds : a compendium of clinical research and practice·2023
Same author

Patient-centered Outcomes for Individuals with a Venous Leg Ulcer: A Scoping Review.

Advances in skin & wound care·2022
Same author

Diabetic foot ulcer: treatment challenges.

Wounds : a compendium of clinical research and practice·2022
Same author

Improving venous ulcer outcomes.

Wounds : a compendium of clinical research and practice·2022
Same author

Local tranexamic acid reduces surgical blood loss.

Wounds : a compendium of clinical research and practice·2022
Same author

Measured Wound Outcome Feedback Improves Surgical Site Infection Rates.

Wounds : a compendium of clinical research and practice·2021
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jan 23, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

3.1K

Preventing Peritoneal Dialysis Infections.

Laura Bolton1

  • 1Department of Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ.

Wounds : a Compendium of Clinical Research and Practice
|June 20, 2019
PubMed
Summary

Peritoneal dialysis (PD) patients face infection risks like peritonitis and exit site infections. Intranasal mupirocin reduced catheter site infections, while intravenous antibiotics lowered peritonitis, indicating distinct interventions for different PD complications.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Clinical Trials

Background:

  • Peritoneal dialysis (PD) is preferred by many end-stage kidney disease patients over hemodialysis.
  • Fears of serious complications, including peritonitis and catheter exit site infections (ESI), deter PD use.
  • Higher incidences of PD-related infections than ISPD guidelines are a concern.

Discussion:

  • Risk factors for PD-related peritonitis include Staphylococcus aureus nasal carriage, diabetes, and obesity.
  • Intranasal mupirocin reduced PD catheter ESI and tunnel infections but not peritonitis.
  • Preoperative intravenous antibiotics decreased early peritonitis but did not impact catheter ESI or tunnel infections.

Key Insights:

  • Peritonitis and ESI/tunnel infections appear to be independent outcomes in PD.

More Related Videos

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

16.0K
Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion
06:23

Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion

Published on: May 23, 2025

2.2K

Related Experiment Videos

Last Updated: Jan 23, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

3.1K
Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

16.0K
Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion
06:23

Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion

Published on: May 23, 2025

2.2K
  • Different interventions may be required to manage these distinct infectious complications.
  • Antimicrobial agents show varied efficacy depending on the type of PD-related infection.
  • Outlook:

    • Further research is needed to optimize antimicrobial strategies for PD patients.
    • Investigating topical antimicrobial agents for PD-related infections is warranted.
    • Understanding the distinct mechanisms of peritonitis and ESI is crucial for prevention.